Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
15.6%
% of IDNA's 49 holdings also in PBE
25.0%
% of PBE's 28 holdings also in IDNA
Overlap by Weight
Sector Drift (IDNA minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IDNA |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 4.8% | 5.5% | 4.8% |
|
REGENERON PHARMACEUTICALS | 4.6% | 5.4% | 4.6% |
|
INCYTE CORP | 4.4% | 5.1% | 4.4% |
|
EXELIXIS INC | 4.7% | 3.1% | 3.1% |
|
DYNAVAX TECHNOLOGIES CORP | 1.6% | 2.4% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to PBE
 |
ROCHE HOLDING LTD | 4.9% |
 |
BEIGENE, LTD. | 4.8% |
 |
SANOFI-AVENTIS | 4.4% |
|
SAREPTA THERAPEUTICS INC | 4.3% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 4.3% |
|
REVOLUTION MEDICINES, INC. | 4.2% |
 |
GSK PLC | 4.1% |
 |
GENMAB A/S | 3.9% |
|
MERCK & CO. INC. | 3.6% |
 |
BIONTECH SE SPONSORED ADR | 3.5% |
IDNA Underweight Relative to PBE
|
ILLUMINA INC | -5.7% |
|
BIOMARIN PHARMACEUTICAL INC | -5.4% |
|
AMGEN INC | -4.9% |
|
VERTEX PHARMACEUTICALS INC | -4.9% |
|
NEUROCRINE BIOSCIENCES INC | -4.0% |
|
HALOZYME THERAPEUTICS INC | -3.6% |
|
VERACYTE INC | -3.6% |
|
TG THERAPEUTICS INC | -3.4% |
|
UNITED THERAPEUTICS CORP | -3.3% |
|
IONIS PHARMACEUTICALS, INC. | -3.1% |